T-Cell Therapy Market Growth Analysis Report 2022 – 2030
Acumen Research and Consulting has recently published a research report on the T-Cell Therapy Market for the forecast period of 2022-2030, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the T-Cell Therapy Market offers an extensive analysis of how the T-Cell Therapy Market landscape would evolve through 2026. A deep dive study on this industry has enabled our research analysts to precisely analyze the T-Cell Therapy Market size. Additionally, our T-Cell Therapy Market forecast numbers have been updated on account of the impact COVID-19 pandemic and this has helped us to estimate the final worldwide T-Cell Therapy Market value.
The research study on the T-Cell Therapy Market analyzes key drivers upholding product sales and prominent trends shaping the growth of the market. The research study not only focuses on the latent opportunities for the key stakeholders of the market but also sheds light on the notable developments and future scope for innovation in the landscape
Download Sample Report Copy Of This Report From Here: https://www.acumenresearchandconsulting.com/request-sample/2494
The report starts with a quick executive summary, wherein, key takeaways have been highlighted for the readers to have a sneak peek at the key market segments. In addition, the research study also focuses on T-Cell Therapy Market trends that are responsible for market growth. The research study by Acumen Research and Consulting on the market also talks about the macroeconomic and microeconomic factors having deep-rooted influences on global T-Cell Therapy Market growth. The research study on the T-Cell Therapy Market industry analysis also offers a regional analysis, wherein, demand across every region has been comprehensively analyzed.
Our T-Cell Therapy Market regional outlook will allow you to comprehend information on a worldwide level. Besides that, it will make you easily uncover the T-Cell Therapy Market shares of all the segmentations and regions.
Key Vendors Included as below:
Some of the players considered in the report scope are Novartis AG, Merck KGaA, Gilead Sciences Inc., TCR2 Therapeutics Inc., Bluebird Bio Inc., and Sorrento Therapeutics.
Key Questions Answered in the Report
The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-
- What is the overall structure of the market?
- What was the historical value and what is the forecasted value of the market?
- What are the key product level trends in the market?
- What are the market level trends in the market?
- Which of the market players are leading and what are their key differential strategies to retain their stronghold?
- Which are the most lucrative regions in the market space?
T-Cell Therapy Market Segmentation for this report is as below:
Market By Modality
Research
Commercialized
Market By Therapy Type
CAR T-cell Therapy
T-Cell Receptor (TCR)-based
Tumor Infiltrating Lymphocytes (TIL)-based
Market By Indication
Hematologic Malignancies
• Lymphoma
• Leukemia
• Myeloma
Solid Tumors
• Melanoma
• Brain & Central Nervous System
• Liver Cancer
• Others
Others
Table of Content:
CHAPTER 1. Industry Overview of T-cell Therapy
1.1. Definition and Scope
1.1.1. Definition of T-cell Therapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global T-cell Therapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. T-cell Therapy Market By Modality
1.2.3. T-cell Therapy Market By Therapy Type
1.2.4. T-cell Therapy Market By Indication
1.2.5. T-cell Therapy Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of T-cell Therapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for T-cell Therapy Market
3.7. Value Chain Analysis
3.8. Cost Structure Analysis
3.8.1. Proportion of Manufacturing Cost Structure
3.8.1.1. Raw Material
3.8.1.2. Labor Cost
3.8.1.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of T-cell Therapy Major Manufacturers in 2019
CHAPTER 5. T-cell Therapy Market By Modality
5.1. Introduction
5.2. T-cell Therapy Revenue By Modality
5.2.1. T-cell Therapy Revenue (US$ Mn) and Forecast, By Modality, 2016-2027
5.2.2. Research
5.2.2.1. Research Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Commercialized
5.2.3.1. Commercialized Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. T-cell Therapy Market Revenue By Therapy Type
6.1. Introduction
6.2. T-cell Therapy Revenue (US$ Mn) By Therapy Type
6.2.1. T-cell Therapy Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
6.2.2. CAR T-cell Therapy
6.2.2.1. CAR T-cell Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. T Cell Receptor (TCR)-based
6.2.3.1. T Cell Receptor (TCR)-based Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Tumor Infiltrating Lymphocytes (TIL)-based
6.2.4.1. Tumor Infiltrating Lymphocytes (TIL)-based Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. T-cell Therapy Market By Indication
7.1. Introduction
7.2. T-cell Therapy Revenue (US$ Mn) By Indication
7.2.1. T-cell Therapy Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
7.2.2. Hematologic Malignancies
7.2.2.1. Hematologic Malignancies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.2.2. Lymphoma
7.2.2.3. Leukemia
7.2.2.4. Myeloma
7.2.3. Solid Tumors
7.2.3.1. Solid Tumors Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3.2. Melanoma
7.2.3.3. Brain & Central Nervous System
7.2.3.4. Liver Cancer
7.2.3.5. Others
7.2.4. Others
7.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America T-cell Therapy Market By Country
8.1. North America T-cell Therapy Overview
8.2. U.S.
8.2.1. U.S. T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
8.2.2. U.S. T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
8.2.3. U.S. T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
8.3. Canada
8.3.1. Canada T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
8.3.2. Canada T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
8.3.3. Canada T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe T-cell Therapy Market By Country
9.1. Europe T-cell Therapy Market Overview
9.2. U.K.
9.2.1. U.K. T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
9.2.2. U.K. T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
9.2.3. U.K. T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
9.3. Germany
9.3.1. Germany T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
9.3.2. Germany T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
9.3.3. Germany T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
9.4. France
9.4.1. France T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
9.4.2. France T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
9.4.3. France T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
9.5. Spain
9.5.1. Spain T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
9.5.2. Spain T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
9.5.3. Spain T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
9.6.2. Rest of Europe T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
9.6.3. Rest of Europe T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific T-cell Therapy Market By Country
10.1. Asia Pacific T-cell Therapy Market Overview
10.2. China
10.2.1. China T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
10.2.2. China T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
10.2.3. China T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
10.3. Japan
10.3.1. Japan T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
10.3.2. Japan T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
10.3.3. Japan T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
10.4. India
10.4.1. India T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
10.4.2. India T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
10.4.3. India T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
10.5. Australia
10.5.1. Australia T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
10.5.2. Australia T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
10.5.3. Australia T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
10.6. South Korea
10.6.1. South Korea T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
10.6.2. South Korea T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
10.6.3. South Korea T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
10.7.2. Rest of Asia-Pacific T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
10.7.3. Rest of Asia-Pacific T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America T-cell Therapy Market By Country
11.1. Latin America T-cell Therapy Market Overview
11.2. Brazil
11.2.1. Brazil T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
11.2.2. Brazil T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
11.2.3. Brazil T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
11.3. Mexico
11.3.1. Mexico T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
11.3.2. Mexico T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
11.3.3. Mexico T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
11.4.2. Rest of Latin America T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
CHAPTER 12. Middle East & Africa T-cell Therapy Market By Country
12.1. Middle East & Africa T-cell Therapy Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
12.2.2. Saudi Arabia T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
12.2.3. Saudi Arabia T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
12.3. UAE
12.3.1. UAE T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
12.3.2. UAE T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
12.3.3. UAE T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
12.4.2. Rest of Middle East & Africa T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
12.4.3. Rest of Middle East & Africa T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
CHAPTER 13. PLAYER ANALYSIS OF T-CELL THERAPY
13.1. T-cell Therapy Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global T-cell Therapy Market
CHAPTER 14. COMPANY PROFILE
14.1. Novartis AG
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Novartis AG 2019 T-cell Therapy Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Merck KGaA
14.3. Gilead Sciences Inc.
14.4. TCR2 Therapeutics Inc
14.5. Bluebird Bio Inc.
14.6. Sorrento Therapeutics
14.7. Fate Therapeutics
14.8. Pfizer Inc.
14.9. Amgen
14.10. Celgene Corporation
14.11. Others
Ask Query Here: sales@acumenresearchandconsulting.com
To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/2494
About Us
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
Contact Us:
Mr. Frank Wilson
Acumen Research and Consulting
USA: +13474743864
India: +918983225533
E-mail: sales@acumenresearchandconsulting.com